← SynDRA
ALOE-EMODIN
SynDRA canonical compound SYN0002141 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CASP3 | CASP8 |
|---|
| Mechanism of action | anticancer agent |
|---|
All known targets
Mechanisms of action (all sources)
- anticancer agent
- ALDH3A2 INHIBITOR
Cross-references
Synonyms
- Aloe emodin
- Aloeemodin
- Aloe-emodine
- Rhabarberone
- EMODINE
- 3-Hydroxymethylchrysazin
- 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione
- 3-Hydroxymethylchrysazine
- 1,8-Dihydroxy-3-hydroxymethylanthraquinone
- 1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone
- NSC 38628
- 1,8-Dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione
- UNII-C8IYT9CR7C
- 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-
- CCRIS 3526
- EINECS 207-571-7
- C8IYT9CR7C
- 3-(Hydroxymethyl)chrysazin
- BRN 2059062
- CHEMBL40275
- CHEBI:2607
- DTXCID0010695
- RefChem:27157
- Aloe emodin (Standard)
- MFCD00017373
- 1,8-dihydroxy-3-hydroxymethyl-anthraquinone
- NSC38628
- 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone
- Anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-
- Aloe-emodol
- SMR000470920
- Diacerein EP Impurity B
- aloe-emodinin
- AloeEmodine
- Aloeemodin;
- Rottlerin?
- Aloe-emodin;
- Rhabarberone (Standard)
- Diacerein impurity B CRS
Look up ALOE-EMODIN in the interactive SynDRA portal →